Flagship explainer
What drives CYTEK BIOSCIENCES, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$66.5M | FY2025 |
| |
| Income before tax | −$29.8M | FY2025 |
|
| Operating income | −$40.4M | FY2025 |
|
| $201M | FY2025 |
| |
| Ending assets | $462M | FY2025 |
|
| Beginning assets | $500M | FY2024 |
|
| $342M | FY2025 |
| |
| $396M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001628280-26-012352